Literature DB >> 16523622

Use of genetic strains of chickens in studies of ovarian cancer.

P A Johnson1, J R Giles.   

Abstract

Ovarian cancer is a deadly disease often diagnosed late in development when there is little chance for a successful recovery. Although ovarian cancer is a rare occurrence in most animals, the domestic hen has been shown to spontaneously develop the disease with an age-related incidence. Two strains of hens derived from a similar genetic background and maintained at Cornell University have been shown to differ in the incidence of the disease. At 2 yr of age, the C strain hens have a greater incidence of ovarian neoplasms than do K strain hens. Interestingly, levels of plasma estradiol are elevated in the C strain compared with K strain hens. In addition, plasma immunoreactive inhibin is lower in the C strain than in the K strain. Finally, mRNA expression of the alpha-subunit of inhibin in the granulosa cell layer of the large yellow follicles is lower in the C strain compared with the K strain hens. Further studies using these as well as other strains of hens may be useful in learning more about the etiology of this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523622     DOI: 10.1093/ps/85.2.246

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  16 in total

1.  Retinoic acid (RA) and bone morphogenetic protein 4 (BMP4) restore the germline competence of in vitro cultured chicken blastodermal cells.

Authors:  Xiaochuan Tang; Jun Shi; Xiaolian Qin; Ning Xiao; Rongyang Li; Hao Hu; Fengshuo Yang; Deshun Shi; Xiaoli Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-02-08       Impact factor: 2.416

2.  Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner.

Authors:  Anushka Dikshit; Manoel Adrião Gomes Filho; Erfan Eilati; Stacey McGee; Carrie Small; Chunqi Gao; Thomas Klug; Dale Buchanan Hales
Journal:  Br J Nutr       Date:  2015-04-08       Impact factor: 3.718

3.  Oral contraceptives decrease the prevalence of ovarian cancer in the hen.

Authors:  Lindsey S Treviño; Elizabeth L Buckles; Patricia A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

Review 4.  The chicken model of spontaneous ovarian cancer.

Authors:  Adam M Hawkridge
Journal:  Proteomics Clin Appl       Date:  2014-10       Impact factor: 3.494

5.  The PeptideAtlas of the Domestic Laying Hen.

Authors:  James McCord; Zhi Sun; Eric W Deutsch; Robert L Moritz; David C Muddiman
Journal:  J Proteome Res       Date:  2017-02-14       Impact factor: 4.466

6.  The hen as a model of ovarian cancer.

Authors:  Patricia A Johnson; James R Giles
Journal:  Nat Rev Cancer       Date:  2013-05-16       Impact factor: 60.716

7.  Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus).

Authors:  Dale Buchanan Hales; Yan Zhuge; Jo Ann Jaen Lagman; Kristine Ansenberger; Cassandra Mahon; Animesh Barua; Judith L Luborsky; Janice M Bahr
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

8.  Advantages of the avian model for human ovarian cancer.

Authors:  Ana DE Melo Bernardo; Sólveig Thorsteinsdóttir; Christine L Mummery
Journal:  Mol Clin Oncol       Date:  2015-08-11

9.  Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer.

Authors:  Animesh Barua; Pincas Bitterman; Jacques S Abramowicz; Angela L Dirks; Janice M Bahr; Dale B Hales; Michael J Bradaric; Seby L Edassery; Jacob Rotmensch; Judith L Luborsky
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

10.  Prevalence of antitumor antibodies in laying hen model of human ovarian cancer.

Authors:  Animesh Barua; Seby L Edassery; Pincas Bitterman; Jacques S Abramowicz; Angela L Dirks; Janice M Bahr; Dale B Hales; Michael J Bradaric; Judith L Luborsky
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.